CLINICAL_TRIALS
trial_result
· 2020-11-18
Clinical Trial Update: Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout [Phase 4]
Summary
A Phase 4 trial evaluating pegylated uricase (pegloticase) plus methotrexate for uncontrolled gout has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Gout | Phase 4 | Status: COMPLETED | Results posted: 2020-11-18